HEILONGJIANG ZBD PHARMACEUTICAL revenue breakdown overview

HEILONGJIANG ZBD PHARMACEUTICAL revenue for the last year amounted to 3.14 B CNY, the most of which — 1.60 B CNY — came from its highest performing source at the moment, Chinese Medicine Preparations, the year earlier bringing 871.60 M CNY. The greatest contribution to the revenue figure was made by China — last year it brought HEILONGJIANG ZBD PHARMACEUTICAL 3.14 B CNY, and the year before that — 4.21 B CNY.